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Abstract
A pulmonary embolism (PE) is one of the most common life-threatening cardiological disorders. It is the mechanical 
blockage of a lung artery by a substance, usually a thrombus, that has moved through the bloodstream. The suspicion 
of PE may be based on specific, yet non-characteristic subjective and objective symptoms, including laboratory investi-
gations and the medical history of the patient. For a clinical assessment of the likelihood of PE, two point scales are 
recommended — the Wells Scale and the modified Geneva Score. Imaging tests that can confirm or exclude PE include 
both methods associated with radiation exposure, such as chest radiogram, lung scintigraphy, single-photon emission 
computed tomography, computed tomographic pulmonary angiography or pulmonary angiography, as well as methods 
without radiation exposure such as ultrasonography (where venous compression ultrasound and echocardiography 
are promising, but are not yet ready for widespread use) and magnetic resonance angiography. The choice of imaging 
method depends on the availability of specific medical equipment and the clinical condition of the patient.
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Introduction
Pulmonary embolism (PE) is defined as mechanical 
closure of a part of the vascular bed. The most common 
cause of pulmonary artery embolism is thrombus, rarely 
an embolus (e.g. elements of bone marrow, fat, cancer 
cells, air, and amniotic fluid). Pulmonary embolism and 
deep vein thrombosis Venous thromboembolism (VTE) 
refers to both pulmonary embolism and deep vein throm-
bosis (DVT). The source of thromboembolic material are 
usually deep veins of the thigh and small pelvis, less 
often veins of the lower leg, liver veins and veins of upper 
limbs (e.g. in the case of central catheters maintained to 
long). Thrombi may also originate from the right atrium 
and right ventricle [1]. PE is one of the most common 
cardiac states directly life threatening [1]. It can be fatal 
in its acute phase or lead to chronic disease and disability. 
PE is one of the main causes of mortality, morbidity and 
hospitalizations in Europe [2].
Clinical picture
Based on etiology, PE risk factors are divided into primary 
or secondary. The most important risk factors are: injury, 
large joint surgery (hip, knee), large surgery (3–7 days after 
surgery), large injuries, and spinal cord injuries. Moderate 
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Table 1. Assessment of clinical probability of pulmonary em-
bolism (PE) according to Wells Scale (source [4]) and modified 
Geneva Scale (source [5])
Wells Scale [4]
Variable Number of points
Predisposing factors:
• DVT or PE in the past 1.5







• heart rate > 100/min 1.5
• signs of DVT 3
Clinical evaluation:




Clinical probability (3 levels): Total amount of points
• low 0–1
• moderate 2–6
• high ≥ 7
Clinical probability (2 levels):
• low probability of PE 0–4
• possibility of PE > 4
Modified Geneva Scale [5]
Variable Amount of points
Predisposing factors:
• age > 65-years-old 1
• DVT or PE in the past 3
• surgery or fracture during 
the last month
2
• cancer (not cured) 2
Symptoms:
• unilateral lower limb pain 3
• hemoptysis 2
Signs:
• heart rate          75–94/min 3
≥ 95/min 5
• pain when pressure applied 
to deep veins of the lower 
limb and unilateral swelling
4
Interpretation
Clinical probability (3 levels): Total amount of points
• low 0–3
• moderate 4–10
• high ≥ 11
DVT — deep vein thrombosis
risk factors include: history of DVT, arthroscopy of the knee 
joint, central venous catheter in lying patients, cancer 
and its treatment (mainly chemotherapy), thrombophilia, 
paresis, heart failure, pregnancy and puerperium, hormone 
replacement therapy, oral contraception. Low risk factors 
are: immobilization for more than 3 days, long journey, 
age > 40 years, obesity, varicose veins. The coexistence of 
certain clinical conditions with advanced age or pregnancy 
results in a multiplication of risk and a higher risk of PE 
[3]. Pulmonary embolism may also occur in the absence 
of any known risk factor [2].
Symptoms of PE are not characteristic, but most pa-
tients experience dyspnea, chest pain, accelerated respi-
ration rate. Less frequent symptoms include paroxysmal 
cough, weakness, fainting, haemoptysis, tachycardia, aus-
cultatory changes over the lungs, fever, symptoms of lower 
limb venous thrombosis [3]. It should be remembered that 
PE may be completely asymptomatic and may be detected 
accidentally during diagnostic tests associated with another 
disease or during autopsy [2]. The variety of occurrence 
and severity of symptoms often requires differentiation 
with acute coronary syndrome, pneumonia, infection or 
neuralgia. Therefore, it is important to determine the 
clinical probability of pulmonary embolism based on the 
analysis of risk factors, complaints reported by patients, 
symptoms and initial examinations, which target further 
management [3].
Laboratory tests used in the diagnostics of PE include 
arterial blood gasometry, D-dimer concentration, cardiac 
troponins and natriuretic peptides. Determination of 
D-dimer concentration is of high exclusion value, but it 
is not specific and positive results may occur in other 
diseases (sepsis, cancer, connective tissue diseases, 
heart failure, kidney failure, heart attack with shock, DIC 
syndrome, severe liver damage, severe trauma, advanced 
age, pregnancy). On the other hand, elevated values of 
cardiac markers are predictive indicators of high mortality, 
right ventricular overload and show significant prognostic 
value [3].
In order to differentiate with other cardiovascular 
diseases, echocardiography is performed, preceded by 
electrocardiography (ECG).
In the assessment of clinical probability of PE, two-point 
scales are currently used - the Wells Scale and the modified 
Geneva Scale (Table 1) [4, 5], which enable diagnostics and 
interpretation of additional test results [3].
The next step after clinical suspicion is imaging diagno-
stics. Imaging methods used in the diagnosis of PE include: 
chest radiography, angiotomography of pulmonary arteries, 
magnetic resonance angiography, V/P scan, SPECT scan, 
pulmonary arteriography, deep vein ultrasonography of 
lower extremities and echocardiography.
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Chest X-ray
Thoracic radiogram is the basic diagnostic method of 
respiratory system changes, however, it does not allow 
for differentiation of PE. With the help of this examination 
it is possible to exclude diseases in which symptoms are 
similar to those of PE, such as pneumothorax, fracture of 
ribs, pneumonia, pleural disease, cancer of the lungs [1]. 
Patients with PE have symptoms of pulmonary hypertension 
on the X-ray of the chest, i.e. enlarged heart with visible 
right ventricular enlargement [6]. The PA radiogram view 
shows a leftward shift of the outlining of the heart, with 
the rounding and elevation of the apex over the diaphragm, 
while the profile radiogram shows an increased adhesion 
of the figure of the heart to the sternum [7]; dilatation of 
pulmonary artery and proximal segments of pulmonary 
arteries or contraction of peripheral pulmonary arteries 
during the leak reversal phase (Eisenmenger reaction). In 
the pulmonary parenchyma, lung infarction can be seen as 
a shade of the pulmonary parenchyma similar in shape to 
a triangle with the base pointing to the pleura (Hampton’s 
symptom) [6]. On the infarction side there is often a small 
pleural exudate, diaphragm lift, atelectasis, and multiple 
unilateral or bilateral infarcts. These foci are reabsorbed 
within a few weeks or they break down and form an abscess.
In about half of the cases of pulmonary embolism, 
infarction does not occur due to the formation of collateral 
circulation through the bronchial arteries [7]. The area of 
local lung ischemia in the form of increased transparency 
and reduced number of vessels (Westermark symptom) 
is very rarely visible. It should be stressed that a normal 
chest X-ray image of the lungs and heart does not exclude 
pulmonary embolism [6].
Ventilation/perfusion scan
Lung perfusion scintigraphy is a functional radioisotope 
examination. The most commonly used radiopharmaceu-
ticals are microspheres or macro-aggregates of human 
blood albumin (MAA) which are 15–50 µm in diameter and 
are administered intravenously, labelled with the isomer of 
technetium isotope 99mTc. They are distributed in a similar 
way to erythrocytes; due to their size, they are retained in 
precapillary and capillary vessels, which makes it possible 
to evaluate perfusion [6]. 
Immediately after administration of the marker, acquisi-
tion is performed in anterior, posterior, lateral right and left 
projections, as well as right and left diagonal projections [6]. 
A scintigraphy camera is used to record data in the form of 
a projection of the distribution of radioactivity in the tested 
body. Such a set of projections forming a direct image is 
called planar imaging. The scintigraphic image is analogous 
to a flat X-ray image, with the difference that the observed 
radiation comes from the inside of the patient’s body. The 
disadvantage of planar imaging is the overlapping of radio-
activity from different structures located on one line [8]. Per-
fusion scintigraphy is a sensitive but non-specific method. 
Pulmonary circulation disorders visible in scintigraphy may 
also result from other disorders leading to limited ventilation 
of the selected lung area due to segmental airway obstru-
ction, pulmonary parenchymal diseases, cardiovascular 
malformations or heart disease [6]. The basic criterion for 
the diagnosis of PE based on perfusion scintigraphy is the 
presence of losses in the collection of the marker including 
with the location of anatomical lung segments and a normal 
chest X-ray image [6]. Perfusion scans are combined with 
ventilation testing, which uses various markers such as 
xenon (133Xe), 99mTc marked aerosols or 99mTc marked carbon 
microparticles (Technegas). Additional ventilation scans are 
performed to increase the specificity of the study: in acute 
PE, ventilation is expected to be normal in areas of hypo-
perfusion [ventilation-perfusion incompatibility (mismatch)]. 
Performing only a perfusion test is acceptable inpatients 
with normal chest X-ray results; in this situation, any loss of 
perfusion will be considered a mismatch [2].
Lung scintigraphy results are often classified according 
to the criteria established in the PIOPED (Prospective Inve-
stigation of Pulmonary Embolism Diagnosis) study. A three-
-stage classification is preferred: normal scan (excluding 
pulmonary embolism), high probability scan (considered 
diagnostic for pulmonary embolism in most patients) and 
non-diagnostic scan [2]. In order to reduce the probability 
of non-diagnostic results, modified PIOPED — PIOPED II and 
PISAPED (Prospective Investigative Study of Acute Pulmo-
nary Embolism Diagnosis) [9] (Table 2) criteria are applied.
Results indicating an indirect probability of pulmonary 
embolism cannot be the basis for a diagnostic decision; 
the diagnosis should be verified by other available imaging 
studies. The reasons for undiagnostic images include 
technical limitations related to single-plane mapping of 
the distribution of radioactivity in lung projection in the 
classic scintigraphic method [6]. According to data from the 
International Commission on Radiological Projection (ICRP), 
exposure to radiation during lung scintigraphy using 99mTc 
labeled albumin with a radioactivity of 100 MBq reaches 
1.1 mSv for adults and is significantly lower compared to 
the doses used in spiral computed tomography.
Since we use less contrast and lower radiation dose 
during scintigraphy, we use it in outpatient patients with 
low clinical probability and normal chest X-ray, in young 
patients (especially women), pregnant women, patients 
with history of anaphylaxis after using a contrast agent, 
with positive allergic history, severe renal failure, patients 
with myeloma and paraproteinemia [2].
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Single-photon emission computed  
tomography (SPECT)
Recent studies indicate that SPECT imaging with or without 
low-dose CT may reduce the incidence of undiagnostic 
scans [2]. Ventilation-perfusion single photon emission 
computed tomography (V/P SPECT) is a study used in the 
field of nuclear medicine. The test method and the radiop-
harmaceuticals used are similar to those used V/P scan. 
The main difference is the way the image is registered.
The SPECT technique requires the use of a rotary 
gamma-camera. During the examination, the camera ro-
tates around the long axis of the patient’s body, recording 
successive projections, which form the basis of three-
-dimensional reconstruction. Appropriate projections with 
the use of mathematical methods make it possible, to 
reconstruct the three-dimensional distribution of the radio-
pharmaceutical in the examined body [8]. SPECT allows you 
to obtain scintigraphic images with much better resolution 
in different planes [6]. Better detection of perfusion losses 
at the subsegmental level was demonstrated, especially in 
the middle parts of the lungs [10].
According to European Association of Nuclear Medici-
ne (EANM) guidelines, PE may be excluded in the case of 
a correct perfusion image consistent with the anatomical 
structure of the lungs, overlapping ventilation and perfusion 
losses, regardless of their size, shape, number and in the 
case of changes that do not correspond to the anatomical 
structure of the lungs. PE is confirmed in the case of at least 
one segmental or two subsegmental perfusion losses [11]. 
Non-specific, complex ventilation and perfusion disorders 
are considered undiagnostic [12].
EANM guidelines also emphasize the importance of 
holistic evaluation of SPECT studies, which includes infor-
mation on clinical status and probability of PE, evaluation 
of chest X-ray, evaluation of pulmonary embolism typical 
changes based on a map of pulmonary segments and le-
sions other than PE [12]. The studies showed that SPECT 
has a higher sensitivity and specificity and a lower number 
of inconclusive results in diagnostics of PE when compared 
to two-dimensional imaging [10]. According to ICRP data, 
exposure to radiation during the V/P SPECT study using 
99mTc-labelled albumin with radioactivity of 100–120 MBq 
Table 2. Modified scintigraphic criteria PIOPED II and PISAPED (source [9])
Diagnosis Modified PIOPED II PISAPED
Confirmation of acute PE ≥ 2 large (> 75% of the segment) segmental perfusion los-
ses without corresponding ventilation disturbances on chest 
X-ray
≥ 1 wedge-shaped loss of perfusion
Exclusion of acute PE Normal perfusion Normal perfusion
Very low probability of 
acute PE
Changes that do not correspond to the lung segments:
• dilation of hilum of the lung
• enlargement of the cardiac silhouette
• diaphragm lift
• atelectasis
• blurring of the costophrenic angle in the absence of per-
fusion losses
Minor losses of perfusion
Perfusion defects smaller than the lesions visible on the 
chest X-ray
Changes caused by:
• enlargement of the cardiac silhou-
ette
• widening of the mediastinal sha-
dow
• diaphragm lift
≤ 3 small (< 25% of the segment) segmental perfusion los-
ses with correct chest X-ray imaging 
Non wedge-shaped perfusion defects
Overlapping ventilation and perfusion defects and interstitial 
shading in the middle or upper pulmonary fields on the chest 
X-ray
Perfusion defects surrounded by areas of normal lung perfu-
sion (stripe sign)
Pleural reaction covering at least 1/3 of the pleura with no 
perfusion losses
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artefacts, banded artefacts associated with high concen-
trations of the contrasting agent in vessels or catheters, 
partial volumetric averaging in the case of vessels diagonal 
to the cross-sectional plane, dilatation of the hilum of the 
lung, weak strengthening of pulmonary circulation vessels, 
presence of bronchial mucus and areas of atelectasis or 
pulmonary parenchyma densification in which the pulmo-
nary arteries are constricted. The above situations may 
imitate the loss of filling with the contrasting agent in the 
vessels lumen [14].
Hurwitz and his team for the study in the protocol for 
the evaluation of pulmonary arteries with the 64-row ap-
paratus determined the radiation dose of 19.9 ± 1.38 mSv 
[15]. Due to the possibility of allergic reactions and contrast 
nephropathy, this method is used in patients with high 
clinical suspicion of PE and elevated levels of D-dimer, in 
whom pulmonary embolism cannot be excluded without 
radiological imaging [16].
Pulmonary artery arteriography
This method has remained a reference method for decades 
in the diagnosis or exclusion of PE [2]. Digital subtraction 
angiography (DSA) is a technique used for final diagnosis 
of PE or DVT when less invasive methods cannot be used 
[14]. It requires less contrast media than conventional 
angiography and has excellent imaging quality of peripheral 
pulmonary vessels in patients who can hold their breath; 
it is less suitable for imaging of the main pulmonary ves-
sels due to artifacts caused by cardiac motion [2]. In the 
procedure, a catheter is inserted through the right heart 
into the pulmonary arteries and the contrasting agent is 
administered selectively [14].
The diagnosis of acute PE is based on direct evidence 
of thrombus presence in two projections or in the form of 
perfusion losses or amputations of the pulmonary artery 
branch. Indirect symptoms of pulmonary embolism, such as 
slow contrast flow, regional hypoperfusion and delayed or 
reduced flow of venous lung blood, are not verified and are 
therefore not diagnostic [2]. If the presence of a thrombus 
is unequivocally detected, the diagnosis can be terminated. 
Patients who are scheduled for surgical removal of the 
thrombus or thrombolytic treatment are an exception, as 
it is necessary to determine the location of the thrombus 
in these patients [14].
Pulmonary arteriography is not without risk of compli-
cations. Complications can be divided into those related to 
the administration of a contrasting agent and secondary 
ones due to catheterization of the heart and pulmonary 
vessels. Mortality during surgery reaches 0.5% and is 
usually a consequence of acute right ventricular failure 
caused by a transient increase in pulmonary artery pres-
sure after administration of a contrasting agent. Deaths 
during pulmonary angiography occur almost exclusively in 
and 99mTc-labelled aerosol with radioactivity of 25–30 MBq 
reaches 1.2–2 mSv [11].
CT pulmonary angiogram
CT pulmonary angiogram is a basic test used in clinically 
stable patients with suspected PE. This is a first-line 
examination in patients with abnormal chest X-ray or hi-
story of cardiopulmonary disease and can be performed 
instead of V/P scan in all other patients [13]. Since the 
introduction of multidirectional CT with high spatial and 
time resolution and good quality of contrasting arterial 
vessels, CT pulmonary angiogram has become a method 
of choice for the assessment of pulmonary vessels in case 
of suspicion of PE [2].
To achieve optimal results, it is essential to choose the 
right time and method of administration of the contrasting 
agent individually. This is particularly important for patients 
where urgent diagnosis is needed, with reduced cardiac 
output and prolonged circulatory time. Determination of the 
individual delay time for image acquisition is based on the 
injection of a trial bolus or a bolus trigger [13].
A better technique is bolus triggering. It works by ta king 
sample monitoring images with a significantly reduced 
radiation dose with an appropriate positioning of the table 
(triggering area) and defining the area of interest (ROI, 
region of interest) in which vascular enhancement will be 
measured. After reaching a sufficient level of enhancement 
(determined visually or by a threshold value of the radiation 
attenuation rate), a proper spiral acquisition begins [13].
Symptoms of acute PE are complete closure of the ar-
tery lumen or loss of filling by the contrasting blood flowing 
through the lumen [6]. Acute blockages are trapped either 
in places where the pulmonary artery bifurcate or in peri-
pheral arteries with diameters smaller than the diameter of 
the thrombus. The 1st ones can occur not only in bifurca-
tion of the pulmonary artery, but also at the segmental or 
subsegmental level. The level of obstruction of the vessel 
corresponds to the diameter of the embolism, i.e. the place 
of its origin [13]. The vessel in which the embolism is located 
is usually dilated [6]. In this case, mosaic perfusion with 
reduced saturation of the affected segment occurs [13].
If the bilateral circulation through the bronchial arteries 
is insufficient, pulmonary infarction may occur after just 
a few hours. Contrasting of the matt glass type may precede 
formation of a typical wedge-shaped segmental densifica-
tion. Larger infarctions may contain varying amounts of 
air. In the unventilated part of the lung, areas suspected 
of infarction show reduced contrast strengthening. Cavities 
are often observed in septic infarctions, less frequently 
in uncomplicated infarctions. Sometimes infarctions are 
accompanied by pneumothorax [13].
Diagnostic traps in the detection of pulmonary embo-
lism in CT angiography result from the presence of motor 
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very severe patients with existing pulmonary hypertension 
or right ventricular dysfunction [14]. In hemodynamically 
unstable patients the volume of the contrast agent sho-
uld be reduced, and non-selective injections should be 
avoided. Serious complications which did not end with 
death occurred in 1% and minor complications occurred 
in 5% of the patients [2]. Because of the relative safety of 
selective administration of non-ionic contrasts and the high 
mortality of untreated pulmonary embolism, it is believed 
that pulmonary artery angiography should be performed 
only if indications are present [14].
MRPA, magnetic resonance angiography
MRPA seems to be a promising method of imaging due to 
the lack of ionizing radiation. Nephrotoxicity and allergic 
reactions after the use of a gadolinium contrast medium 
are less of a problem [16]. However, studies indicate that 
this technique is not yet ready for use in clinical practice 
due to its low sensitivity, high percentage of ambiguous 
tests and low availability in most emergency facilities 
[2]. Motion artifacts of the image and poor filling of seg-
mental and subsegmental vessels are the main reasons 
for undiagnostic examinations. In addition, the study 
may be poorly tolerated by patients with claustrophobia, 
contraindicated during pregnancy and in patients with 
cerebral vascular clips, metal implants and cardiac pa-
cemakers [16].
Compression ultrasound (CUS)
CUS is a non-invasive method of DVT imaging [14]. This is 
an effective, repetitive and best test to reveal deep vein 
thrombosis of the lower extremities and to exclude diseases 
that may resemble deep vein thrombosis, such as rupture 
of Baker’s cyst, subcutaneous tissue inflammation [3], 
lymphadenopathy, pseudoaneurysms or pelvic tumors that 
press the hip veins [14].
In most cases, the source of PE is deep vein throm-
bosis of the lower extremities. In case of suspicion of 
PE, CUS exam may be limited to a simple assessment of 
four sites (groins and knee pits). The diagnostic benefits 
of using CUS in suspected PE can be increased by per-
forming a complete ultrasound examination including 
distal veins [2].
Ultrasonographic signs of venous thrombosis include: 
the vessels lumen does not collapse when pressure is 
applied with the ultrasound probe [6], increase of the ves-
sels diameter by more than 50%, increased echogenicity 
in the lumen of the vessel [17]; in Doppler examination: 
Figure 1. Diagnostic algorithm for patients with suspected pulmonary embolism (PE) in the high-risk group; aalso includes cases in which the patient’s condition allows only to perform bed-
side diagnostic tests; bin addition to the diagnosis of RV dysfunction, bedside echocardiography may (in some cases) directly confirm the PE by visualizing the thrombus in the right heart cavi-
ties. Additional bedside tests include transesophageal echocardiography, which can show obstruction in the pulmonary artery and its branches, as well as bilateral knee ultrasound, which 
can confirm deep vein thrombosis and help in making a therapeutic decision; cthrombolysis, alternatively surgical embolectomy or a catheter; CT — computed tomography; RV — right ventricle
Suspected high risk PE with accompanying shock of hypotony












Search for a different 





Search for a different 
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or the patient 
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Figure 2. Diagnostic algorithm for patients with suspected low risk pulmonary embolism (PE);atwo alternative classification schemes can be used to assess the clinical probability 
of PE: a three-level scheme (low, intermediate and high probability) or a two-level (low probable and probable PE) scheme. The use of tests to determine the concentration of inter-
mediate D-dimer should be reserved for patients with low probability or classified as less likely PE. On the other hand, the high sensitivity tests for the determination of D-dimer can 
also be used in patients with an intermediate probability of PE. D-dimer plasma levels are of limited utility in hospitalized patients with suspected PE; banticoagulant treatment in 
PE; cCT angiography is considered to be diagnostic in PE diagnosis if it shows PE at the segmental level or more proximal; din case of negative CT angiography in patients with high 
probability, further diagnostics should be considered before discontinuation of PE-specific treatment; CT — computed tomography
Suspected PE without shock or hypotony
Low/intermediate clinical probability 
or unlikelyhood of PE
Evaluation of D-dimer levels
Positive resultNegative result
CT angiography
High clinical probability 











bTreatmentbNo treatment  
Clinical probability of PE should be assessed  
Clinical evaluation or predictive scale
absence of flow in spectrum recording and with colored 
flow [6]. The only recognized diagnostic criterion of DVT is 
an incomplete vein compression indicating the presence 
of a thrombus, while the criteria based on blood flow are 
unreliable [2].
A positive proximal CUS result is characterized by 
a high predictive value for PE [2]. Despite the accuracy of 
the method, a negative CUS result does not exclude PE. 
Therefore, in patients with negative pressure test results 
and a high probability of PE [14], diagnosis should be 
continued [18].
Echocardiography
Acute PE may lead to right ventricular pressure overload 
and ventricular dysfunctions, which can be detected by 
echocardiography [2]. Both transthoracic echocardio-
graphy (TTE, transthoracic echocardiography) and tran-
sesophageal echocardiography (TEE, transesophageal 
echocardiography) are used in the diagnosis of PE. TTE 
is the first additional test that should be performed in 
case of suspicion of a massive PE. In this case it allows to 
exclude shock or hypotonia of causes other than PE [1], 
showing the presence of cardiac tamponade, acute valve 
failure, severe impairment of left ventricular function, 
aortic dissection. In high-risk suspicion of PE, with signs 
of shock or hypotonia, the lack of echocardiographic 
features of right ventricular overload or dysfunction 
practically excludes PE as a cause of hemodynamic in-
stability [2]. Echocardiography is not recommended as 
part of a planned diagnostic strategy in hemodynamically 
stable patients with normal blood pressure when PE is 
suspected [2].
Echocardiographic signs — based either on disturbed 
right ventricular ejection (so-called “60/60 symptom”) or 
on impaired right ventricular free wall contractility when 
compared to the apex of the right ventricle (so-called 
“McConnell sign”) have a high positive prognostic value for 
PE, even in the presence of pre-existing cardiopulmonary 
diseases. Additional echocardiographic features of pres-
sure overload should be found to avoid false diagnosis of 
acute PE in patients with hypokinesis or akinesis of the 
right ventricular free wall in the course of right ventricular 
infarction. Right ventricular mobile thrombus is detected 
during TTE or TEE in less than 4% of unsorted patients with 
PE, but their incidence may reach 18% under conditions 
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Streszczenie
Zatorowość płucną (PE) określa się jako jedną z częstszych kardiologicznych przyczyn bezpośredniego zagrożenia życia. 
O PE można mówić w przypadku mechanicznego zamknięcia światła łożyska naczyniowego najczęściej przez płynącą 
z prądem krwi skrzeplinę. Na PE mogą wskazywać określone, choć nieswoiste objawy podmiotowe i przedmiotowe, w tym 
należy brać pod uwagę badania laboratoryjne oraz wywiad chorobowy pacjenta. Zalecane do oceny klinicznego prawdo-
podobieństwa PE są skale punktowe — Wellsa i zmodyfikowana Skala Genewska. Do badań obrazowych, pozwalających 
potwierdzić lub wykluczyć PE, należą: metody z zastosowaniem promieniowania jonizującego, takie jak radiogram klatki 
piersiowej, scyntygrafia płuc, tomografia emisyjna pojedynczego fotonu, angiotomografia tętnic płucnych czy klasyczna 
arteriografia tętnic płucnych; badania bez użycia promieniowania jonizującego, na przykład ultrasonografia — ultraso-
nograficzna próba uciskowa i echokardiografia czy obiecująca metoda, lecz jeszcze niegotowa do powszechnego stoso-
wania — angiografia metodą rezonansu magnetycznego. Wybór metody obrazowania zależy od dostępności określonych 
badań oraz stanu klinicznego pacjenta.
Słowa kluczowe: zatorowość płucna, diagnostyka, przegląd
Folia Cardiologica 2018; 13, 6: 526–533
of intensive surveillance. Mobile thrombi in the right heart 
cavities basically confirm the diagnosis of PE, and their 
presence is associated with right ventricular dysfunction 
and high early mortality [2].
Summary
Currently, the first-line imaging method in patients with 
suspected PE is CT pulmonary angiogram. Numerous 
studies have shown that the negative predictive value of 
CT pulmonary angiogram for PE is over 95%. However, the 
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diagnostic procedure depends on the clinical condition 
of the patient, clinical probability of PE and the available 
diagnostic imaging methods. Based on the guidelines of 
the European Society of Cardiology (ESC) for the diagnosis 
and management of acute PE from 2014, specific diagno-
stic algorithms presented in Figures 1 and 2 [2] may be 
used in the assessment of the above-mentioned factors.
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